1-5 of 5
Anjali Vaze
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cevostamab Monotherapy Continues to Show Clinically Meaningful Activity and Manageable Safety in Patients with Heavily Pre-Treated Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from an Ongoing Phase I Study

Suzanne Trudel, Adam D Cohen, Amrita Y. Krishnan, Rafael Fonseca, Andrew Spencer, Jesús G. Berdeja, Alexander Lesokhin, Peter A Forsberg, Jacob P. Laubach, Luciano J. Costa, Paula Rodriguez-Otero, Rayan Kaedbey, Joshua Richter, Maria-Victoria Mateos, Sheeba K Thomas, Chihunt Wong, Mengsong Li, Voleak Choeurng, Anjali Vaze, Divya Samineni, Teiko Sumiyoshi, James Cooper, Simon J Harrison
Journal: Blood
Blood (2021) 138 (Supplement 1): 157.
https://doi.org/10.1182/blood-2021-147983
Published: 2021
Journal Articles

Initial Clinical Activity and Safety of BFCR4350A, a FcRH5/CD3 T-Cell-Engaging Bispecific Antibody, in Relapsed/Refractory Multiple Myeloma

Adam D. Cohen, MD, Simon J Harrison, MBBS MRCP (UK) PhDFRCPath (UK) FRACP, Amrita Krishnan, MD, Rafael Fonseca, MD, Peter A Forsberg, MD, Andrew Spencer, Jesus G. Berdeja, MD, Jacob P. Laubach, MD, Mengsong Li, Voleak Choeurng, Anjali Vaze, Divya Samineni, Teiko Sumiyoshi, James Cooper, Bernard M Fine, Suzanne Trudel
Journal: Blood
Blood (2020) 136 (Supplement 1): 42–43.
https://doi.org/10.1182/blood-2020-136985
Published: 2020
Journal Articles

Early Pharmacodynamic Changes in T-Cell Activation, Proliferation, and Cytokine Production Confirm the Mode of Action of BFCR4350A, a FcRH5/CD3 T-Cell-Engaging Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma

Rin Nakamura, Sean Lear, Deanna Wilson, Hartmut Koeppen, Anjali Vaze, Suzanne Trudel, MD MSC, FRCPC, Andrew Spencer, Simon J Harrison, MBBS MRCP (UK) PhDFRCPath (UK) FRACP, Adam D. Cohen, MD, Bernard M Fine, Mengsong Li, James Cooper, Teiko Sumiyoshi
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–15.
https://doi.org/10.1182/blood-2020-136980
Published: 2020
Journal Articles

A Phase I Study of the Anti-CD79b THIOMAB TM -Drug Conjugate DCDS0780A in Patients (pts) with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)

Alex F. Herrera, MD, Manish R Patel, MD, John M. Burke, MD, Ranjana H. Advani, MD, Bruce D. Cheson, MD, Jeffrey P. Sharman, MD, Elicia Penuel, Andrew G. Polson, PhD, Ning Leng, PhD, Chunze Li, PhD, Eva Schuth, PhD, Anjali Vaze, PhD, Divya Samineni, PhD, Rebecca Elstrom, MDMA, Catherine S Diefenbach
Journal: Blood
Blood (2017) 130 (Supplement 1): 4129.
https://doi.org/10.1182/blood.V130.Suppl_1.4129.4129
Published: 2017
Journal Articles

Risk of Wernicke’s Encephalopathy in Patients with Myeloproliferative Neoplasm

Jasmanda Wu, PhD, Nadeem Mirza, MD MPH, Angela M. Partisano, PharmD, MS, Christina Gallagher, PharmD, Anjali Vaze, MD, Ling Zhang, MS, Meghan Gallagher, PhD, Stephen Lin, MD, Juhaeri Juhaeri, PhD
Journal: Blood
Blood (2014) 124 (21): 4839.
https://doi.org/10.1182/blood.V124.21.4839.4839
Published: 2014